Infectech, biotechnological company founded in 1989, specializes in the research and development of equipment used in the rapid identification and antibiotic sensitivity testing of disease causing pathogens.
We have made available online our catalogue describing in detail our line of products and ordering information.
To learn more about Infectech, its services, the numerous patents it owns, or to read what others have said in print, select one of these options.
- Spoligotyping
Genprice
Who we are?
Genprice Inc. is an American Distributor of Research Reagents and Diagnostics based in a beautiful area of San Francisco Bay. We are also in Europe under Gentaur Brand with Accounting, Tax Entity and Sales Representatives in 8 countries.
Genprice
Particularities
We are dedicated to serving the needs of the scientific community. So we are providing high quality peptides and bioanalytical reagents. Certainly Recognizing the unbreakable link between the researcher’s tool and his research success. Also, we pay particular attention to the quality of our products. Therfore, all ou products are manufactured with rigorous guidelines and are accompanied by certificates of analysis, HPLC, Mass Spectrum and HMNR data. In contrast, our platform is user-friendly and offers variety of filters within the group to help you narrow down the search. So that you can find the required kit as soon as possible.
We maintain exponential and sustainable growth year-on-year. Hence, with an average annual growth rate of 30% since our establishment in 2000. Therfore, today, we are proud of being one of the largest biotechnology companies in a lot of regions. Above all, contributing to the dynamic development of the biotechnology industry. Also, our long-term international partnership with prestigious universities and research and development organizations, as well as our worldwide distribution network allows us to conduct discoveries on a global scale.
We develop and offer a wide range of products, including test kits, antibodies, recombinant proteins and enzymes. Rather other innovative research tools to study apoptosis, cell proliferation, metabolism, cell damage and repair, cellular stress, diabetes, obesity and metabolic syndrome, core Biology cells, gene regulation, signal transmission etc. Our products are currently sold in over 60 countries around the world. We are well known in the natural sciences industry to provide researchers with research tools that will accelerate their research.
Infectech is at the forefront of developing next-generation technologies for the rapid identification and antibiotic susceptibility testing (AST) of pathogenic microorganisms. Our mission is to equip clinical laboratories and research facilities with high-performance diagnostic tools that meet the rigorous demands of modern microbiology and combat the growing threat of antimicrobial resistance (AMR).
Our Vision
To empower healthcare providers with innovative diagnostic tools that enhance patient outcomes and combat the global challenge of antimicrobial resistance.
Technology Overview
Our solutions integrate the latest advancements in molecular diagnostics, microfluidics, and artificial intelligence to provide unparalleled accuracy, speed, and reliability in identifying pathogens and determining their susceptibility to antibiotics.
Our Solutions
Pathogen Identification Systems:
Rapid and reliable tools to identify bacteria, viruses, and fungi with unparalleled accuracy.
Antibiotic Sensitivity Testing Devices:
Cutting-edge platforms to determine the most effective treatments, combating antibiotic resistance.
Integrated Software:
Intuitive, data-driven software that enhances diagnostic workflows and provides actionable insights.
Core Technologies:
01
Microfluidic Platforms:
Miniaturized systems enabling precise control of sample handling and reagent mixing, reducing assay times and reagent consumption.
02
Automated Imaging and Analysis:
AI-driven systems for real-time detection of microbial growth and phenotypic changes, providing accurate AST results within hours.
03
Genomic and Proteomic Profiling:
Advanced molecular techniques, including PCR, NGS, and MALDI-TOF, for rapid pathogen identification and resistance gene detection.
04
Smart Data Integration:
Cloud-based solutions for managing diagnostic workflows, integrating lab data, and delivering actionable insights to clinicians.
Product Highlights
Rapid Pathogen Identification Systems:
- Technology: Combines molecular assays with MALDI-TOF mass spectrometry for precise and comprehensive microbial identification.
- Performance: Capable of identifying over 1,000 species of bacteria, fungi, and viruses within minutes.
- Applications: Clinical microbiology, environmental testing, and pharmaceutical quality control.
Antibiotic Susceptibility Testing (AST) Devices:
- Phenotypic AST Systems: Measure microbial growth in the presence of antibiotics using real-time optical sensors for MIC determination.
- Genotypic Resistance Detection: Leverages PCR-based methods to identify resistance genes directly from clinical samples.
- Throughput: Supports both high-volume labs and point-of-care settings with scalable options.
Research & Development
Our R&D pipeline focuses on developing faster, more precise methods for emerging pathogens and resistance mechanisms. Current projects include:
Rapid Diagnostics for Multidrug-Resistant Organisms (MDROs):
Addressing the urgent need for accurate tools to combat drug-resistant infections.
Point-of-Care Testing:
Portable, user-friendly devices designed for decentralized diagnostic environments.
AI-Driven Predictive Models:
Utilizing machine learning to predict antibiotic efficacy and optimize treatment protocols.
Why Choose Us?
Speed and Accuracy:
Our solutions are designed to deliver precise results in record time, enabling timely and effective treatment decisions.
Innovation:
We leverage the latest advancements in microbiology, molecular biology, and AI to stay ahead in the fight against infectious diseases.
Reliability:
Trusted by laboratories and healthcare professionals worldwide, our equipment ensures robust performance and consistent outcomes.